This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
This report aims to provide a comprehensive presentation of the global market for Diabetes Therapeutics and Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Therapeutics and Diagnostics. This report contains market size and forecasts of Diabetes Therapeutics and Diagnostics in global, including the following market information:
Global Diabetes Therapeutics and Diagnostics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diabetes Therapeutics and Diagnostics market was valued at US$ 120530 million in 2022 and is projected to reach US$ 142220 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Insulin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diabetes Therapeutics and Diagnostics include 77 Elektronika Kft., A. Menarini Diagnostics S.R.L, Abbott Laboratories, Agamatrix Inc., Animas Corp., Ascensia, Becton Dickinson, Debiotech S.A. and Eli Lilly And Co., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetes Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Therapeutics and Diagnostics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Therapeutics and Diagnostics Market Segment Percentages, by Type, 2022 (%)
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others
Global Diabetes Therapeutics and Diagnostics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diabetes Therapeutics and Diagnostics Market Segment Percentages, by Application, 2022 (%)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others
Global Diabetes Therapeutics and Diagnostics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diabetes Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Therapeutics and Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diabetes Therapeutics and Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Therapeutics and Diagnostics, market overview.
Chapter 2: Global Diabetes Therapeutics and Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Diabetes Therapeutics and Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Therapeutics and Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Diabetes Therapeutics and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Therapeutics and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Therapeutics and Diagnostics Overall Market Size
2.1 Global Diabetes Therapeutics and Diagnostics Market Size: 2022 VS 2029
2.2 Global Diabetes Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Diabetes Therapeutics and Diagnostics Players in Global Market
3.2 Top Global Diabetes Therapeutics and Diagnostics Companies Ranked by Revenue
3.3 Global Diabetes Therapeutics and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Diabetes Therapeutics and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Therapeutics and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Therapeutics and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Therapeutics and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Therapeutics and Diagnostics Market Size Markets, 2022 & 2029
4.1.2 Insulin
4.1.3 Insulin Delivery
4.1.4 Oral Hypoglycemic Drugs
4.1.5 Diagnosis And Monitoring
4.1.6 Others
4.2 By Type - Global Diabetes Therapeutics and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Diabetes Therapeutics and Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Therapeutics and Diagnostics Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Therapeutics and Diagnostics Market Size, 2022 & 2029
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.1.4 Gestational Diabetes
5.1.5 Others
5.2 By Application - Global Diabetes Therapeutics and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Diabetes Therapeutics and Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Therapeutics and Diagnostics Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Therapeutics and Diagnostics Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Therapeutics and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Diabetes Therapeutics and Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Therapeutics and Diagnostics Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Diabetes Therapeutics and Diagnostics Revenue, 2018-2029
6.3.2 US Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.3.3 Canada Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.3.4 Mexico Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Diabetes Therapeutics and Diagnostics Revenue, 2018-2029
6.4.2 Germany Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.3 France Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.4 U.K. Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.5 Italy Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.6 Russia Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.7 Nordic Countries Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.4.8 Benelux Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Diabetes Therapeutics and Diagnostics Revenue, 2018-2029
6.5.2 China Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.5.3 Japan Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.5.4 South Korea Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.5.5 Southeast Asia Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.5.6 India Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Diabetes Therapeutics and Diagnostics Revenue, 2018-2029
6.6.2 Brazil Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.6.3 Argentina Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Therapeutics and Diagnostics Revenue, 2018-2029
6.7.2 Turkey Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.7.3 Israel Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.7.4 Saudi Arabia Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
6.7.5 UAE Diabetes Therapeutics and Diagnostics Market Size, 2018-2029
7 Diabetes Therapeutics and Diagnostics Companies Profiles
7.1 77 Elektronika Kft.
7.1.1 77 Elektronika Kft. Company Summary
7.1.2 77 Elektronika Kft. Business Overview
7.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.1.4 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.1.5 77 Elektronika Kft. Key News & Latest Developments
7.2 A. Menarini Diagnostics S.R.L
7.2.1 A. Menarini Diagnostics S.R.L Company Summary
7.2.2 A. Menarini Diagnostics S.R.L Business Overview
7.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Major Product Offerings
7.2.4 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.2.5 A. Menarini Diagnostics S.R.L Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Major Product Offerings
7.3.4 Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 Agamatrix Inc.
7.4.1 Agamatrix Inc. Company Summary
7.4.2 Agamatrix Inc. Business Overview
7.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.4.4 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Agamatrix Inc. Key News & Latest Developments
7.5 Animas Corp.
7.5.1 Animas Corp. Company Summary
7.5.2 Animas Corp. Business Overview
7.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.5.4 Animas Corp. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Animas Corp. Key News & Latest Developments
7.6 Ascensia
7.6.1 Ascensia Company Summary
7.6.2 Ascensia Business Overview
7.6.3 Ascensia Diabetes Therapeutics and Diagnostics Major Product Offerings
7.6.4 Ascensia Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Ascensia Key News & Latest Developments
7.7 Becton Dickinson
7.7.1 Becton Dickinson Company Summary
7.7.2 Becton Dickinson Business Overview
7.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Major Product Offerings
7.7.4 Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Becton Dickinson Key News & Latest Developments
7.8 Debiotech S.A.
7.8.1 Debiotech S.A. Company Summary
7.8.2 Debiotech S.A. Business Overview
7.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.8.4 Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Debiotech S.A. Key News & Latest Developments
7.9 Eli Lilly And Co.
7.9.1 Eli Lilly And Co. Company Summary
7.9.2 Eli Lilly And Co. Business Overview
7.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.9.4 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Eli Lilly And Co. Key News & Latest Developments
7.10 Glaxo Smithkline
7.10.1 Glaxo Smithkline Company Summary
7.10.2 Glaxo Smithkline Business Overview
7.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Major Product Offerings
7.10.4 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Glaxo Smithkline Key News & Latest Developments
7.11 Inlight Solutions Inc.
7.11.1 Inlight Solutions Inc. Company Summary
7.11.2 Inlight Solutions Inc. Business Overview
7.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.11.4 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.11.5 Inlight Solutions Inc. Key News & Latest Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Company Summary
7.12.2 Johnson & Johnson Business Overview
7.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Major Product Offerings
7.12.4 Johnson & Johnson Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.12.5 Johnson & Johnson Key News & Latest Developments
7.13 Lifescan Inc.
7.13.1 Lifescan Inc. Company Summary
7.13.2 Lifescan Inc. Business Overview
7.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.13.4 Lifescan Inc. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.13.5 Lifescan Inc. Key News & Latest Developments
7.14 Medtronic
7.14.1 Medtronic Company Summary
7.14.2 Medtronic Business Overview
7.14.3 Medtronic Diabetes Therapeutics and Diagnostics Major Product Offerings
7.14.4 Medtronic Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.14.5 Medtronic Key News & Latest Developments
7.15 Merck & Co.
7.15.1 Merck & Co. Company Summary
7.15.2 Merck & Co. Business Overview
7.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.15.4 Merck & Co. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.15.5 Merck & Co. Key News & Latest Developments
7.16 Merck KGAA
7.16.1 Merck KGAA Company Summary
7.16.2 Merck KGAA Business Overview
7.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Major Product Offerings
7.16.4 Merck KGAA Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.16.5 Merck KGAA Key News & Latest Developments
7.17 Nipro Corp.
7.17.1 Nipro Corp. Company Summary
7.17.2 Nipro Corp. Business Overview
7.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.17.4 Nipro Corp. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.17.5 Nipro Corp. Key News & Latest Developments
7.18 Novartis Pharma Ag
7.18.1 Novartis Pharma Ag Company Summary
7.18.2 Novartis Pharma Ag Business Overview
7.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Major Product Offerings
7.18.4 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.18.5 Novartis Pharma Ag Key News & Latest Developments
7.19 Novo Nordisk A/S
7.19.1 Novo Nordisk A/S Company Summary
7.19.2 Novo Nordisk A/S Business Overview
7.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Major Product Offerings
7.19.4 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.19.5 Novo Nordisk A/S Key News & Latest Developments
7.20 Owen Mumford Ltd.
7.20.1 Owen Mumford Ltd. Company Summary
7.20.2 Owen Mumford Ltd. Business Overview
7.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.20.4 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.20.5 Owen Mumford Ltd. Key News & Latest Developments
7.21 Palco Labs Inc.
7.21.1 Palco Labs Inc. Company Summary
7.21.2 Palco Labs Inc. Business Overview
7.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.21.4 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.21.5 Palco Labs Inc. Key News & Latest Developments
7.22 Roche
7.22.1 Roche Company Summary
7.22.2 Roche Business Overview
7.22.3 Roche Diabetes Therapeutics and Diagnostics Major Product Offerings
7.22.4 Roche Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.22.5 Roche Key News & Latest Developments
7.23 Sanofi
7.23.1 Sanofi Company Summary
7.23.2 Sanofi Business Overview
7.23.3 Sanofi Diabetes Therapeutics and Diagnostics Major Product Offerings
7.23.4 Sanofi Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.23.5 Sanofi Key News & Latest Developments
7.24 Takeda Pharmaceutical Co. Ltd.
7.24.1 Takeda Pharmaceutical Co. Ltd. Company Summary
7.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview
7.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.24.4 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.24.5 Takeda Pharmaceutical Co. Ltd. Key News & Latest Developments
7.25 Terumo Corp.
7.25.1 Terumo Corp. Company Summary
7.25.2 Terumo Corp. Business Overview
7.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Major Product Offerings
7.25.4 Terumo Corp. Diabetes Therapeutics and Diagnostics Revenue in Global Market (2018-2023)
7.25.5 Terumo Corp. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Diabetes Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Diabetes Therapeutics and Diagnostics Market Drivers in Global Market
Table 3. Diabetes Therapeutics and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Diabetes Therapeutics and Diagnostics in Global Market
Table 5. Top Diabetes Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Diabetes Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Diabetes Therapeutics and Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Diabetes Therapeutics and Diagnostics Product Type
Table 9. List of Global Tier 1 Diabetes Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Diabetes Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Diabetes Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Diabetes Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Diabetes Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Diabetes Therapeutics and Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Diabetes Therapeutics and Diagnostics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2024-2029
Table 30. 77 Elektronika Kft. Company Summary
Table 31. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product Offerings
Table 32. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. 77 Elektronika Kft. Key News & Latest Developments
Table 34. A. Menarini Diagnostics S.R.L Company Summary
Table 35. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product Offerings
Table 36. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. A. Menarini Diagnostics S.R.L Key News & Latest Developments
Table 38. Abbott Laboratories Company Summary
Table 39. Abbott Laboratories Diabetes Therapeutics and Diagnostics Product Offerings
Table 40. Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Laboratories Key News & Latest Developments
Table 42. Agamatrix Inc. Company Summary
Table 43. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product Offerings
Table 44. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Agamatrix Inc. Key News & Latest Developments
Table 46. Animas Corp. Company Summary
Table 47. Animas Corp. Diabetes Therapeutics and Diagnostics Product Offerings
Table 48. Animas Corp. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Animas Corp. Key News & Latest Developments
Table 50. Ascensia Company Summary
Table 51. Ascensia Diabetes Therapeutics and Diagnostics Product Offerings
Table 52. Ascensia Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Ascensia Key News & Latest Developments
Table 54. Becton Dickinson Company Summary
Table 55. Becton Dickinson Diabetes Therapeutics and Diagnostics Product Offerings
Table 56. Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Becton Dickinson Key News & Latest Developments
Table 58. Debiotech S.A. Company Summary
Table 59. Debiotech S.A. Diabetes Therapeutics and Diagnostics Product Offerings
Table 60. Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Debiotech S.A. Key News & Latest Developments
Table 62. Eli Lilly And Co. Company Summary
Table 63. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product Offerings
Table 64. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Eli Lilly And Co. Key News & Latest Developments
Table 66. Glaxo Smithkline Company Summary
Table 67. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product Offerings
Table 68. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Glaxo Smithkline Key News & Latest Developments
Table 70. Inlight Solutions Inc. Company Summary
Table 71. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product Offerings
Table 72. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 73. Inlight Solutions Inc. Key News & Latest Developments
Table 74. Johnson & Johnson Company Summary
Table 75. Johnson & Johnson Diabetes Therapeutics and Diagnostics Product Offerings
Table 76. Johnson & Johnson Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 77. Johnson & Johnson Key News & Latest Developments
Table 78. Lifescan Inc. Company Summary
Table 79. Lifescan Inc. Diabetes Therapeutics and Diagnostics Product Offerings
Table 80. Lifescan Inc. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 81. Lifescan Inc. Key News & Latest Developments
Table 82. Medtronic Company Summary
Table 83. Medtronic Diabetes Therapeutics and Diagnostics Product Offerings
Table 84. Medtronic Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 85. Medtronic Key News & Latest Developments
Table 86. Merck & Co. Company Summary
Table 87. Merck & Co. Diabetes Therapeutics and Diagnostics Product Offerings
Table 88. Merck & Co. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 89. Merck & Co. Key News & Latest Developments
Table 90. Merck KGAA Company Summary
Table 91. Merck KGAA Diabetes Therapeutics and Diagnostics Product Offerings
Table 92. Merck KGAA Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 93. Merck KGAA Key News & Latest Developments
Table 94. Nipro Corp. Company Summary
Table 95. Nipro Corp. Diabetes Therapeutics and Diagnostics Product Offerings
Table 96. Nipro Corp. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 97. Nipro Corp. Key News & Latest Developments
Table 98. Novartis Pharma Ag Company Summary
Table 99. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product Offerings
Table 100. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 101. Novartis Pharma Ag Key News & Latest Developments
Table 102. Novo Nordisk A/S Company Summary
Table 103. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product Offerings
Table 104. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 105. Novo Nordisk A/S Key News & Latest Developments
Table 106. Owen Mumford Ltd. Company Summary
Table 107. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product Offerings
Table 108. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 109. Owen Mumford Ltd. Key News & Latest Developments
Table 110. Palco Labs Inc. Company Summary
Table 111. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product Offerings
Table 112. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 113. Palco Labs Inc. Key News & Latest Developments
Table 114. Roche Company Summary
Table 115. Roche Diabetes Therapeutics and Diagnostics Product Offerings
Table 116. Roche Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 117. Roche Key News & Latest Developments
Table 118. Sanofi Company Summary
Table 119. Sanofi Diabetes Therapeutics and Diagnostics Product Offerings
Table 120. Sanofi Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 121. Sanofi Key News & Latest Developments
Table 122. Takeda Pharmaceutical Co. Ltd. Company Summary
Table 123. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Product Offerings
Table 124. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 125. Takeda Pharmaceutical Co. Ltd. Key News & Latest Developments
Table 126. Terumo Corp. Company Summary
Table 127. Terumo Corp. Diabetes Therapeutics and Diagnostics Product Offerings
Table 128. Terumo Corp. Diabetes Therapeutics and Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 129. Terumo Corp. Key News & Latest Developments
List of Figures
Figure 1. Diabetes Therapeutics and Diagnostics Segment by Type in 2022
Figure 2. Diabetes Therapeutics and Diagnostics Segment by Application in 2022
Figure 3. Global Diabetes Therapeutics and Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Therapeutics and Diagnostics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Therapeutics and Diagnostics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2022
Figure 8. By Type - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 16. US Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 20. Germany Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 21. France Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 28. China Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 32. India Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 34. Brazil Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Diabetes Therapeutics and Diagnostics Revenue Market Share, 2018-2029
Figure 37. Turkey Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Diabetes Therapeutics and Diagnostics Revenue, (US$, Mn), 2018-2029
Figure 41. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Laboratories Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Animas Corp. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Ascensia Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Becton Dickinson Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Debiotech S.A. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Johnson & Johnson Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Lifescan Inc. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Medtronic Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Merck & Co. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Merck KGAA Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nipro Corp. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Roche Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Sanofi Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Terumo Corp. Diabetes Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
